Literature DB >> 28898700

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.

Surendra K Shukla, Vinee Purohit, Kamiya Mehla, Venugopal Gunda, Nina V Chaika, Enza Vernucci, Ryan J King, Jaime Abrego, Gennifer D Goode, Aneesha Dasgupta, Alysha L Illies, Teklab Gebregiworgis, Bingbing Dai, Jithesh J Augustine, Divya Murthy, Kuldeep S Attri, Oksana Mashadova, Paul M Grandgenett, Robert Powers, Quan P Ly, Audrey J Lazenby, Jean L Grem, Fang Yu, José M Matés, John M Asara, Jung-Whan Kim, Jordan H Hankins, Colin Weekes, Michael A Hollingsworth, Natalie J Serkova, Aaron R Sasson, Jason B Fleming, Jennifer M Oliveto, Costas A Lyssiotis, Lewis C Cantley, Lyudmyla Berim, Pankaj K Singh.   

Abstract

Entities:  

Year:  2017        PMID： 28898700     DOI： 10.1016/j.ccell.2017.08.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  30 in total

Review 1.  The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

Authors:  Douglas E Biancur; Alec C Kimmelman
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-24       Impact factor: 10.680

2.  O-GlcNAc Transferase Links Glucose Metabolism to MAVS-Mediated Antiviral Innate Immunity.

Authors:  Tianliang Li; Xinghui Li; Kuldeep S Attri; Changhong Liu; Lupeng Li; Laura E Herring; John M Asara; Yu L Lei; Pankaj K Singh; Chengjiang Gao; Haitao Wen
Journal:  Cell Host Microbe       Date:  2018-12-12       Impact factor: 21.023

3.  Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer.

Authors:  Meifang Yu; Nicholas D Nguyen; Yanqing Huang; Daniel Lin; Tara N Fujimoto; Jessica M Molkentine; Amit Deorukhkar; Ya'an Kang; F Anthony San Lucas; Conrad J Fernandes; Eugene J Koay; Sonal Gupta; Haoqiang Ying; Albert C Koong; Joseph M Herman; Jason B Fleming; Anirban Maitra; Cullen M Taniguchi
Journal:  JCI Insight       Date:  2019-07-23

4.  The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression.

Authors:  Yann Wallez; Charles R Dunlop; Timothy Isaac Johnson; Siang-Boon Koh; Chiara Fornari; James W T Yates; Sandra Bernaldo de Quirós Fernández; Alan Lau; Frances M Richards; Duncan I Jodrell
Journal:  Mol Cancer Ther       Date:  2018-06-11       Impact factor: 6.261

5.  Genome profiling of mismatch repair genes in eight types of tumors.

Authors:  Siqi Wang; Gefei Guan; Cunyi Zou; Qing Guo; Wen Cheng; Shuai Shen; Fang Dong; Anhua Wu; Guang Li; Chen Zhu
Journal:  Cell Cycle       Date:  2021-05-09       Impact factor: 4.534

Review 6.  Preclinical Applications of Multi-Platform Imaging in Animal Models of Cancer.

Authors:  Natalie J Serkova; Kristine Glunde; Chad R Haney; Mohammed Farhoud; Alexandra De Lille; Elizabeth F Redente; Dmitri Simberg; David C Westerly; Lynn Griffin; Ralph P Mason
Journal:  Cancer Res       Date:  2020-12-01       Impact factor: 13.312

7.  Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation.

Authors:  Francesca Ricciardiello; Yang Gang; Roberta Palorini; Quanxiao Li; Marco Giampà; Fangyu Zhao; Lei You; Barbara La Ferla; Humberto De Vitto; Wenfang Guan; Jin Gu; Taiping Zhang; Yupei Zhao; Ferdinando Chiaradonna
Journal:  Oncogene       Date:  2020-03-31       Impact factor: 9.867

Review 8.  Cell death in pancreatic cancer: from pathogenesis to therapy.

Authors:  Xin Chen; Herbert J Zeh; Rui Kang; Guido Kroemer; Daolin Tang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-07-30       Impact factor: 46.802

9.  Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.

Authors:  Iman M Ahmad; Alicia J Dafferner; Kelly A O'Connell; Kamiya Mehla; Bradley E Britigan; Michael A Hollingsworth; Maher Y Abdalla
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

10.  Inhibition of de novo pyrimidine synthesis augments Gemcitabine induced growth inhibition in an immunocompetent model of pancreatic cancer.

Authors:  Thuy Phan; Vu H Nguyen; Ralf Buettner; Corey Morales; Lifeng Yang; Paul Wong; Weiman Tsai; Marcela d'Alincourt Salazar; Ziv Gil; Don J Diamond; Joshua D Rabinowitz; Steven Rosen; Laleh G Melstrom
Journal:  Int J Biol Sci       Date:  2021-06-01       Impact factor: 6.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.